跳至主要内容
临床试验/NCT05242640
NCT05242640已完成不适用

Understanding Components of Mind-body Exercise for Physical Activity Engagement in Metabolic Syndrome

Beth Israel Deaconess Medical Center1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2023年1月31日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
34
试验地点
1
主要终点
Perspectives on study interventions

研究概览

简要总结

The aim of this study is to assess the feasibility and acceptability (e.g., enrollment, adherence, retention, acceptability of procedures and interventions) of a pilot factorial study design that will help elucidate components of mind-body exercise interventions. The study involves completing a walking program, a mindful attention program, a walking program that includes mindful attention, or no program at all. A "pilot" study is a smaller study that helps researchers to understand whether the study design can be carried out and what participants think about the study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Metabolic syndrome, defined as meeting 3 or more of the following criteria in the last 12 months at the time of medical record review: (a) BMI ≥ 25; (b) fasting glucose ≥ 100 [5.6 mmol/L] or A1C ≥ 5.7 or medications; (c) blood pressure ≥ 130 systolic or ≥ 85 diastolic or medications; (d) triglycerides ≥ 150 or 1.7 mmol/L or medications; (e) or HDL < 40mg/ dL for men and 50mg/dL for women or medications;
  • insufficiently active, defined as a score ≤ 23 (moderate-to-strenuous units) on Godin-Shepard Leisure-Time Physical Activity Questionnaire;
  • age 18-70 years;
  • given medical clearance for moderate-intensity exercise and exercise stress testing by their primary care physician (PCP);
  • access to a device with internet and videoconferencing capabilities

排除标准

  • current diagnosis of any of the following: (a) coronary artery disease or other chronic heart diseases (e.g., heart failure) in which exercise would be contraindicated or that would preclude HRV analyses (e.g., some arrhythmias); (b) any diabetes; (c) chronic obstructive pulmonary disease or other severe lung dysfunction (e.g., severe asthma); (d) severe cognitive impairment
  • >2 self-reported classes or self-guided mindfulness or mindful movement sessions per week in past 3 months
  • self-reported inability to speak and read in English
  • current beta blocker or calcium channel blocker medication
  • uncontrolled hypertension, defined as resting blood pressure ≥ 150 systolic or ≥ 90 diastolic in the last 6 months
  • self- or physician-reported contraindications for exercise (e.g., severe balance impairment, musculoskeletal restrictions)

研究组 & 干预措施

Mindful attention

Experimental

16 sessions over 8 weeks (2x/week) of mindful attention audio recordings delivered via headphones

干预措施: Mindful attention (Other)

Exercise

Experimental

16 sessions over 8 weeks (2x/week) of moderate-intensity treadmill walking

干预措施: Exercise (Other)

Exercise with mindful attention

Experimental

16 sessions over 8 weeks (2x/week) of moderate-intensity treadmill walking utilizing mindful attention audio recordings delivered via headphones

干预措施: Exercise with mindful attention (Other)

No intervention

No Intervention

No intervention sessions

结局指标

主要结局

Perspectives on study interventions

时间窗: Post-intervention (after 8 week intervention)

Perspectives on study interventions will be assessed via exit interview

Feasibility of screening: screened to eligible ratio

时间窗: Through study completion, an average of 1 year

percent of screened individuals that were determined eligible for the study

Feasibility of retention: retention at each assessment

时间窗: 6 months

percent of enrolled participants retained at post-intervention and 3-month follow-up; determined to be feasible if greater than or equal to 70% retention at each assessment

Feasibility of interventions: attendance rates for each session

时间窗: 6 months

percent session attendance; determined to be feasible if participants attend greater than or equal to 75% of sessions

Feasibility of survey completion: survey completion rates at each assessment

时间窗: 6 months

percent of participants that complete surveys at post-intervention and 3-month follow-up

Acceptability of interventions

时间窗: 6 months

Acceptability of the interventions will be assessed via overall satisfaction (1 = not at all to 10 = very much); determined to be acceptable if mean rating is greater than or equal to 7.5 across 80% of sessions

Feasibility of enrollment: eligible to enrollment ratio

时间窗: Through study completion, an average of 1 year

percent of eligible individuals that enroll in the study; determined to be feasible if greater than or equal to 70% of eligible patients enroll

Acceptability of study design

时间窗: 6 months

Acceptability of the study design will be assessed via acceptability of study procedures (1= not at all to 10 = very much); determined to be acceptable if mean rating is greater than or equal to 7.5 across 80% of sessions

次要结局

  • Heart rate dynamics(Baseline (week 0), post-intervention (after 8 week intervention))
  • Emotion regulation(Baseline (week 0), post-intervention (after 8 week intervention), 3 months post-intervention)
  • Ventilatory efficiency(Baseline (week 0), post-intervention (after 8 week intervention))
  • Positive affect(Baseline (week 0), post-intervention (after 8 week intervention), 3 months post-intervention)
  • Interoceptive awareness(Baseline (week 0), post-intervention (after 8 week intervention), 3 months post-intervention)
  • In-session oxygen consumption(Weeks 1 and 8)
  • In-session respiration rate(Weeks 1 and 8)
  • Self-efficacy(Baseline (week 0), post-intervention (after 8 week intervention), 3 months post-intervention)
  • Self-reported physical activity(Baseline (week 0), post-intervention (after 8 week intervention), 3 months post-intervention)
  • In-session heart rate(Weeks 1 and 8)
  • In-session ventilatory efficiency(Weeks 1 and 8)
  • Objective physical activity(Baseline (week 0), post-intervention (after 8 week intervention))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kristen Kraemer

Instructor of Medicine

Beth Israel Deaconess Medical Center

研究点 (1)

Loading locations...

相似试验